Investor Relations
May 2, 2012

Evonik successfully concludes sale of Colorants business

Following the approval of the Evonik Supervisory Board and the relevant antitrust authorities, Evonik Industries has successfully concluded the sale of the global colorants business. The transaction was closed on April 30, 2012. The new owner is the U.S. private equity firm Arsenal Capital Partners, New York. By mutual agreement the financial terms are not being disclosed.

The Colorants business develops, produces, and markets colorants under the COLORTREND® brand name for decorative applications in the architectural sector. Furthermore, CHROMA-CHEM® products are used in industry, for example for maintenance and in marine and wood coatings. Evonik generated sales of about €130 m from its Colorants business in the year 2011. More than 300 employees, integrated into a global organization, work for Colorants in production plants and laboratories as well as sales and marketing offices. These sites are located in the U.S., Canada, Brazil, Australia, China, Malaysia, and the Netherlands.

Information on Arsenal Capital Partners
Arsenal Capital Partners is a leading private equity firm headquartered in New York, USA. Arsenal invests in medium-sized industrial enterprises, in the health sector, and in financial service providers. Its portfolio includes several investments in the chemicals sector and a number of chemical companies.

Company Information

Evonik, the creative industrial group from Germany, is one of the world leaders
in specialty chemicals. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Evonik benefits specifically from its innovative prowess and integrated technology platforms.

Evonik is active in over 100 countries around the world. In fiscal 2011 more than 33,000 employees generated sales of around €14.5 billion and an operating profit (EBITDA) of about €2.8 billion.


In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.